Concepedia

Kévin Vanvarenberg

KV

Statistics

Publications

28

Citations

1.1K

H-Index

20

Active since

2015

Affiliations

UCLouvain(Current)

de Duve Institute

Solvay (Belgium)

Centre National de la Recherche Scientifique

Institute of Oncology Ljubljana

Kévin Vanvarenberg is an author at UCLouvain specializing in drug delivery, pharmacy, and oncology.

Publications per year

2015–2024

28

Publications

28

Injectable nanomedicine hydrogel for local chemotherapy of glioblastoma after surgical resection

Chiara Bastiancich, John Bianco, Kévin Vanvarenberg et al. · Journal of Controlled Release · 2017 · 151 citations

, , +16

Lauroyl-gemcitabine-loaded lipid nanocapsule hydrogel for the treatment of glioblastoma

Chiara Bastiancich, Kévin Vanvarenberg, Bernard Učakar et al. · Journal of Controlled Release · 2016 · 131 citations

, , +12

Temozolomide-loaded photopolymerizable PEG-DMA-based hydrogel for the treatment of glioblastoma

Thibaut Fourniols, Luc D. Randolph, Aurélie Staub et al. · Journal of Controlled Release · 2015 · 122 citations · Full text

, , +12

Delivery of siRNA targeting tumor metabolism using non-covalent PEGylated chitosan nanoparticles: Identification of an optimal combination of ligand structure, linker and grafting method

Cyril Corbet, Héloïse Ragelle, Vincent Pourcelle et al. · Journal of Controlled Release · 2015 · 84 citations

, , +17

Intracellular siRNA delivery dynamics of integrin-targeted, PEGylated chitosan–poly(ethylene imine) hybrid nanoparticles: A mechanistic insight

Héloïse Ragelle, Stefano Colombo, Vincent Pourcelle et al. · Journal of Controlled Release · 2015 · 59 citations

, , +17

1–5 of 28